Wenxue Gao

Wenxue Gao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2023 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
XZXin Zhao
Xin Zhao
FYFang Yin
Fang Yin
LFLuoqin Fu
Luoqin Fu
YMYingyu Ma
Yingyu Ma
LYLuyi Ye
Luyi Ye
XMXiao-Zhou Mou
Xiao-Zhou Mou

22 December 2023 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
KXKe Xu
Ke Xu
WFWenchao Fei
Wenchao Fei
WGWenxue Gao
Wenxue Gao
CFChangxiu Fan
Changxiu Fan
YLYinghua Li
Yinghua Li
RCRan Cui
Ran Cui
Osteoporosis is a chronic disease that seriously affects the quality of life and longevity of the elderly, so exploring the mechanism of osteoporosis is crucial for drug development and treatment. Bone marrow mesenchymal stem cells are stem cells with multiple differentiation potentials in bone marrow, and changing their differentiation direction can change bone mass. As an extracellular superoxide dismutase, Superoxide Dismutase 3 (SOD3) has been proved to play an important role in multiple organs, but the detailed mechanism of action in bone metabolism is still unclear. In this study, the results of clinical serum samples ELISA and single cell sequencing chip analysis proved that the expression of SOD3 was positively correlated with bone mass, and SOD3 was mainly expressed in osteoblasts and adipocytes and rarely expressed in osteoblasts in BMSCs. In vitro experiments showed that SOD3 can promote osteogenesis and inhibit adipogenesis. Compared with WT mice, the mice that were knocked out of SOD3 had a significant decrease in bone mineral density and significant changes in related parameters. The results of HE and IHC staining suggested that knocking out SOD3 would lead to fat accumulation in the bone marrow cavity and weakened osteogenesis. Both in vitro and in vivo experiments indicated that SOD3 affects bone metabolism by promoting osteogenesis and inhibiting adipogenesis. The results of transcriptome sequencing and revalidation showed that SOD3 can affect the expression of FLT1. Through in vitro experiments, we proved that FLT1 can also promote osteogenesis and inhibit adipogenesis. In addition, through the repeated experiments, the interaction between the two molecules (SOD3 and FLT1) was verified again. Finally, it was verified by WB that SOD3 regulates FLT1 to affect bone metabolism through PI3K/AKT and MAPK pathways.

30 October 2021 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
RCRan Cui
Ran Cui
ZZZheng Zhao
Zheng Zhao
ZFZhaoliang Fei
Zhaoliang Fei
YLYinghua Li
Yinghua Li
WGWenxue Gao
Wenxue Gao

24 October 2022 in Frontiers in Chemistry
Verified
Journal Article
Open access
STShanshi Tong
Shanshi Tong
ZYZhilong Yu
Zhilong Yu
FYFang Yin
Fang Yin
QYQilin Yang
Qilin Yang
JCJuhang Chu
Juhang Chu
MQMingping Qian
Mingping Qian
Pancreatic cancer (PC) is one of the deadliest gastrointestinal malignancies. Advances in molecular biology and surgery have significantly improved survival rates for other tumors in recent decades, but clinical outcomes for PC remained relatively unchanged. Chemodynamic therapy (CDT) and Photothermal therapy (PTT) represent an efficient and relatively safe cancer treatment modality. Here, we synthesized Mn-doped Prussian blue nanoparticles (MnPB NPs) through a simple and mild method, which have a high loading capacity for drugs and excellent CDT/PTT effect. Cell line experiments in vitro and animal experiments in vivo proved the safety of MnPB NPs. We stimulated the PC cells with MnPB NPs and performed transwell migration assays. The migration of PC cells was reduced company with the decrease of two classical proteins: matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). Moreover, MnPB NPs induced ferroptosis, which mediated the MAPK pathway and achieved tumor elimination in nude mice. This effective and safe strategy controlled by irradiation represents a promising strategy for pancreatic cancer.

2 February 2022 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
RCRan Cui
Ran Cui
XXXu Xiaojuan
Xu Xiaojuan
WGWenxue Gao
Wenxue Gao
ZFZhaoliang Fei
Zhaoliang Fei
HSHui Sheng
Hui Sheng
QSQu Shen
Qu Shen

25 May 2025 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZZZheng Zhao
Zheng Zhao
JLJizhou Liang
Jizhou Liang
JKJingrui Kang
Jingrui Kang
JHJing He
Jing He
MLMin Li
Min Li
RCRan Cui
Ran Cui
Diabetic neuropathy (DN) is a common complication of type 2 diabetes mellitus (T2DM), yet its impact on bone mineral density (BMD) remains unclear. This study combines cross-sectional and meta-analytic methods to comprehensively explore the relationship between DN and osteoporosis in T2DM patients. The cross-sectional study included 523 T2DM patients, classified into DN and non-DN groups. BMD was measured using dual-energy X-ray absorptiometry (DXA), and multivariate analysis identified osteoporosis-related factors. The meta-analysis included studies published from 1999 to 2021, comparing BMD between patients with and without DN. The results showed that while significant differences in clinical characteristics and biochemical indices (such as age, HbA1c, and 25(OH) vitamin D levels) were observed between the groups, no significant association between DN and osteoporosis was found after adjusting for covariates like body mass index and blood pressure. Additionally, the meta-analysis confirmed no significant impact of DN on BMD across skeletal sites, including the lumbar spine, hip, and femoral neck. These findings suggest that while DN may indirectly affect bone health through alterations in bone metabolism (such as bone formation markers), its direct impact on BMD is limited. The study's limitations include its cross-sectional design, which restricts causal inference, and retrospective data collection, underscoring the need for prospective studies to further elucidate the mechanisms behind DN’s effects on bone health. These results highlight the complex interplay of factors influencing osteoporosis risk in T2DM and underscore the importance of a multifactorial approach to bone health management in this population.